Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CMPS
Stock Latest News
The Fly
Psychedelic: Exclusive talk with retreat provider ONE Retreats
11d ago
ATAI
CMND
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
17d ago
ATAI
CMND
Premium
The Fly
Psychedelic: atai Life Sciences, NRx report quarterly results
18d ago
ATAI
CMND
Premium
The Fly
Compass Pathways announces published study on psilocybin in depression
21d ago
CMPS
Premium
The Fly
Psychedelic: MindMed reports Q4 earnings results
1M ago
ATAI
CMND
Premium
The Fly
Compass one of the most compelling stories in neuropsych, says H.C. Wainwright
1M ago
CMPS
Premium
Ratings
COMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry with COMP360 Advancements
1M ago
CMPS
Premium
Ratings
Optimistic Buy Rating for COMPASS Pathways: Strategic Trials and Strong Financial Position Bolster Confidence in COMP360’s Potential
1M ago
CMPS
Premium
Ratings
Buy Rating for COMPASS Pathways: Promising Phase 3 Trial Progress and Strong Financial Position
1M ago
CMPS
Premium
The Fly
Compass Pathways price target lowered to $15 from $23 at Canaccord
1M ago
CMPS
Premium
Company Announcements
Compass Pathways Reports 2024 Financial Results and Progress
1M ago
CMPS
Premium
Company Announcements
COMPASS Pathways’ Earnings Call: Progress Amid Challenges
1M ago
CMPS
Premium
The Fly
Psychedelic: GH Research, Compass Pathways report earnings results
1M ago
ATAI
CMND
Premium
The Fly
Compass Pathways reports Q4 EPS (63c), consensus (62c)
1M ago
CMPS
Premium
The Fly
Compass Pathways sees FY25 net cash use $120M-$145M
1M ago
CMPS
Premium
Ratings
Positive Outlook for COMPASS Pathways Amid Psychedelic Acceptance and Strategic Investment Opportunity
1M ago
CMPS
Premium
The Fly
Compass Pathways initiated with a Buy at Stifel
1M ago
CMPS
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
2M ago
ATAI
CMND
Premium
The Fly
Compass Pathways price target lowered to $45 from $60 at H.C. Wainwright
2M ago
CMPS
Premium
The Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
2M ago
ATAI
CMND
Premium
The Fly
Psychedelic: atai Life Sciences reports BPL-003 study results
2M ago
ATAI
CMND
Premium
The Fly
Rising High: Exclusive talk with MSO ETHOS Cannabis
2M ago
ACB
CGC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
